Journals / Medicine Science / 2020 / Cilt: 9 - Sayı: 2

Following-up the long-term efficacy of hepatitis B vaccine in immunization of risky occupational groups

Pages
443–449
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Adult vaccination is as important as childhood vaccination especially in occupational health and safety.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hepatitis B virus (HBV) infection is very common and contagious public health problem with serious pathological consequences (i.e. chronic liver failure, cirrhosis, hepatocellular carcinoma).
📊
Key Findings & Data:In the study, 2512 cases from 12 different occupational groups with HBV exposure risk who were applied to Ankara Occupational and Environmental Diseases Hospital Occupational Diseases Clinic for medical screening between October 2012 and November 2018 were examined and assessed.
💡
Conclusion & Impact:Adult vaccination is as important as childhood vaccination especially in occupational health and safety.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Özet

Hepatitis B virus (HBV) infection is very common and contagious public health problem with serious pathological consequences (i.e. chronic liver failure, cirrhosis, hepatocellular carcinoma). Since HBV is frequently reported as an occupational disease factor, exposure risk is a concerning problem especially in health-care personnel. The aim of this study is to evaluate the time-dependent change of anti-HBs titer levels in various occupational groups. In the study, 2512 cases from 12 different occupational groups with HBV exposure risk who were applied to Ankara Occupational and Environmental Diseases Hospital Occupational Diseases Clinic for medical screening between October 2012 and November 2018 were examined and assessed. Protective titer levels of anti-HBs were determined in 64.8% people in the risky occupational group. HBV seropositivity rates were found as highest in dentists (94.5%) and lowest in kitchen workers (40.1%). The protective anti-HBs titer level in healthcare workers (i.e. dentist, x-ray technician, supporter healthcare personnel) was found to be 89.4%. Those with anti-HBs titer protective level (≥ 10 mIU / ml) were defined as Group-1 (n=1631), and those with Ab level (<10 mIU / ml) who were vaccination recommended and called for re-control defined as Group-2 (n=832). After the followe-up period, it was determined that the anti HBs titer fell below the protective level in 3% of Group-1, while 44.8% (n: 175) in Group-2 were vaccinated and all were immunized. This data shows that despite occupational exposure risk, vaccination following-up is not sufficient in workplace health units. Consequently, anti-HBs levels of workers who will work in high HBV exposure risky occupations should be screened and a vaccination program should be designated for those without protective titer level. Anti-HBs levels should be monitored since decrease in protective titer level depending on time. Adult vaccination is as important as childhood vaccination especially in occupational health and safety.

🔖

Cite This Article

GÜNDÜZÖZ, M., BÜYÜKŞEKERCİ, M., ÖZAKINCI, O. G., DİP, A., İRİTAŞ, S. B., TELATAR, B. (2020). Following-up the long-term efficacy of hepatitis B vaccine in immunization of risky occupational groups. Medicine Science, Cilt: 9 - Sayı: 2, 443–449. https://ajindex.com/articles/272613

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Hepatitis B fact sheet. In: World Health Organization: media centre July 2016 update. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b accessed date 04.23.2020
  2. Global Hepatitis Report 2017, page 9.ISBN 978-92-4-156545- 5, Geneva: World Health Organization;2017. https://apps.who. int/iris/bitstream/handle/10665/255016/9789241565455-eng.pdf; jsessionid=BCDD1746BC15449CCA67A7DBAA1BA8A0?sequence=1 accessed date 04.22.2020
  3. Szeszenia-Dąbrowska N, & Wilczyńska U. Occupational diseases in Poland-An overview of current trends, Int J Occup Med Environ Health. 2013;26:457-70
  4. Hamborsky J, Kroger A, Wolfe S.13th edition. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Chapter 10: Hepatitis B, page:167, Washington D.C. Public Health Foundation, 2015. Available at: https://www.cdc.gov/vaccines/pubs/ pinkbook/index.html 5. Turkey Viral Hepatitis Prevention and Control Program, page 6, ISBN: 978-975-590-688-1 Ministry of Health Publication No 1102, 2018, Ankara. Available at: https://hsgm.saglik.gov.trdepo/birimler/Bulasici-hastaliklar-db/ duyurular/Turkiye_ Viral_Hepatit_Onleme_ve Kontrol_ Programi/ Turkiye_ Viral_Hepatit_ Onleme_ve_ Kontrol_Programi_TR.pdf 6. Weekly Epidemiological Record (WER), World Health Organization. October 2009; 84 (40): 405-20. Available at: https://www.who.int/wer/2009/ wer8440.pdf?ua=1 7. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Inf Dis. 2011;53:68-75
  5. Averhoff F, Mahoney F, Coleman P, et al. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. Am J Prev Med. 1998;15:1-8
  6. Coppeta L, Pompei A, Balbi O, et al. Persistence of immunity for hepatitis B virus among heathcare workers and italian medical students 20 years after vaccination. Int J Environ Res Public Health. 2019;16:1515
  7. Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. Recommendations and Reports /January12, 2018; 67(1):1-31. https://www.cdc.gov/mmwr/volumes/67/rr/rr6701a1. htm?scid=rr6701a1_w
  8. Schillie S, Murphy TV, Sawyer M, et al. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep 2013;62(No. RR-10):1– 19. Available at:https://www.cdc.gov/ mmwr/ preview/mmwrhtml/rr6210a1.